title: Dialysis modalities and dyslipidemia.
abstract: Progressive renal failure is accompanied by dyslipidemia, which is reflected in an abnormal apolipoprotein profile. It is characterized by increased concentrations of intact and partially metabolized triglyceride-rich apoB-containing lipoproteins. They occur preferentially in very-low density lipoprotein (VLDL) and low-density lipoprotein (LDL) as a result of impaired metabolism and clearance. Hemodialysis can moderately attenuate the renal dyslipidemia. In contrast, peritoneal dialysis is associated with further aggravation, including an increase of cholesterol-rich apoB-containing lipoproteins.
authors.affiliation: Department of Nephrology, Sahlgrenska University Hospital, Göteborg, Sweden. per-ola.attman@vgregion.se
authors.forename: Per-Ola
authors.initials: PO
authors.lastname: Attman
authors.forename: Ola
authors.initials: O
authors.lastname: Samuelsson
authors.forename: Ann-Cathrine
authors.initials: AC
authors.lastname: Johansson
authors.forename: James B
authors.initials: JB
authors.lastname: Moberly
authors.forename: Petar
authors.initials: P
authors.lastname: Alaupovic
mesh_terms: D006801:Humans; D006949:Hyperlipidemias / Q000150:complications / Q000628:therapy*; D007676:Kidney Failure, Chronic / Q000150:complications / Q000628:therapy*; D010530:Peritoneal Dialysis; D006435:Renal Dialysis